Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ORPHAN DIAGNOSTICS HOLDING AS
AS
Active
Org 818000472
Annen forskning og annet utviklingsarbeid innen naturvitenskap og teknikk · NACE 72190
Est. 2016
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2021
NOK 0
EBITDA margin
—
-368% vs 2020
Equity ratio
33.5%
Financial strength
Net profit 2021
NOK -16K
-368% vs 2020
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2017
0M
0%
2018
0M
0%
2019
0M
0%
2020
0M
0%
2021
Key figures
Annual report 2021
Revenue
NOK 0
—
EBITDA
NOK -16K
-368%
Net profit
NOK -16K
-368%
Total assets
NOK 30K
+2%
Equity
NOK 10K
-62%
Employees
0
—
Company information
Legal name
ORPHAN DIAGNOSTICS HOLDING AS
Org number
818000472
Legal form
Aksjeselskap
NACE code
72190 · Annen forskning og annet utviklingsarbeid innen naturvitenskap og teknikk
Founded
4. november 2016
Share capital
NOK 3 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Eie aksjer i orphan diagnostics as
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Annen forskning og annet utviklingsarbeid innen naturvitenskap og teknikk
Companies in
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
0M
2020
0M
2021
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
0M
2020
0M
2021
Income statement
NOK thousands
Item
2017
2018
2019
2020
2021
Revenue
0
0
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
0
0
0
−4
−16
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
0
0
0
−4
−16
Net financials
0
0
0
0
0
Profit before tax
0
0
0
−4
−16
Tax
−0
−0
−0
−0
−0
Net profit
0
0
0
−4
−16
Balance sheet
NOK thousands
Item
2017
2018
2019
2020
2021
Total assets
30
30
30
29
30
Equity
30
30
30
26
10
Long-term debt
0
0
0
0
0
Short-term debt
0
0
0
3
20
Total debt
0
0
0
3
20
Financial ratios
5-year trend
EBITDA margin
-1647000.0%
This company
15.8%
Market median
-10424151% vs market
2017
2021
Equity ratio
33.5%
This company
38.2%
Market median
+12% vs market
2017
2021
Return on equity
-164.5%
This company
18.4%
Market median
-994% vs market
2017
2021
Net profit margin
-1647000.0%
This company
8.1%
Market median
-20333433% vs market
2017
2021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2017
2021
Debt / equity
1.98×
This company
0.62×
Market median
-219% vs market
2017
2021
Annual reports & filings
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
GG
Gaut Gadeholt
Board of Directors
2016
—
—
DJ
Dag Jacobsen
Board of Directors
2016
—
—
KE
Knut Erik Hovda
Chairman
2016
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ORPHAN DIAGNOSTICS HOLDING AS also hold positions in
0
other companies.
Person
Role here
Other companies
Gaut Gadeholt
Board of Directors
0 companies
Dag Jacobsen
Board of Directors
0 companies
Knut Erik Hovda
Chairman
0 companies